We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

MRI in Ovarian Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05769205
Recruitment Status : Not yet recruiting
First Posted : March 15, 2023
Last Update Posted : March 15, 2023
Sponsor:
Collaborator:
principle investigator
Information provided by (Responsible Party):
Maryam Farouk Mahmoud Sayed, Assiut University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Role of multi paramrtric MRI and MRI perfusion in indetermint ovarian lesions by using ORADS MRI

Condition or disease Intervention/treatment Phase
Ovarian Neoplasms Device: MRI Not Applicable

Detailed Description:
Aim of study the purpose of this study is to investigate the capabilities of multi parametric MRI including DCE perfusion and DWI to discriminate between benign and malignant ovarian masses .
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional
Estimated Enrollment : 25 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: females with ovarian masses
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Role of Multi Paramertic MRI and MRI Perfusion in Indetermint Ovarian Lesions by Using ORADS MRI
Estimated Study Start Date : March 2023
Estimated Primary Completion Date : March 2025
Estimated Study Completion Date : December 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ovarian Cancer

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: female with ovarian masses
MRI with contrast according to the kidney function test of the patients
 Device: MRI
MRI with contrast


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. MRI in ovarian tumors [ Time Frame: 2 years ]
    Role of parametric MRI in determint ovarian lesions by using ORADS MRI


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Ovaries lesions
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria: females with ovarian masses

-

Exclusion Criteria:

  • females with known benign ovarian masses
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05769205


Contacts
Layout table for location contacts
Contact: Maryam Farouk Sayed 01064353498 Faroukmariam54@gmail.com
Contact: Mostafa Hashem hashemradiol@yahoo.com

Sponsors and Collaborators
Assiut University
principle investigator
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Layout table for additonal information
Responsible Party: Maryam Farouk Mahmoud Sayed, Assiut university, Assiut University
ClinicalTrials.gov Identifier: NCT05769205    
Other Study ID Numbers: MRI in ovarian tumors
First Posted: March 15, 2023    Key Record Dates
Last Update Posted: March 15, 2023
Last Verified: February 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Ovarian Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Ovarian Diseases
 Adnexal Diseases
Genital Neoplasms, Female
Urogenital Neoplasms
Endocrine System Diseases
Gonadal Disorders